Results 81 to 90 of about 898,102 (296)

Image_2_Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.tif

open access: yes, 2021
Histone deacetylases (HDAC) are frequently overexpressed in tumors, and their inhibition has shown promising anti-tumor effects. However, the synergistic effects of HDAC inhibition with immune cell therapy have not been fully explored. Natural killer (NK)
Adeleye O. Adeshakin (11358672)   +8 more
core   +1 more source

USP4‐Dependent CHAF1B Stabilization Regulates Distinct SETDB1 Ubiquitin States Linked to AKT T308 Signaling and Lipogenic Remodeling in HCC

open access: yesAdvanced Science, EarlyView.
USP4 stabilizes CHAF1B by limiting K48‐linked ubiquitination. Stabilized CHAF1B supports UHRF1‐associated K63‐linked SETDB1 ubiquitination and cytoplasmic redistribution, whereas CHAF1B loss favors VHL‐dependent K11‐associated degradative ubiquitination and proteasomal loss of SETDB1.
Saiyan Bian   +9 more
wiley   +1 more source

Image_1_Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.tif

open access: yes, 2021
Histone deacetylases (HDAC) are frequently overexpressed in tumors, and their inhibition has shown promising anti-tumor effects. However, the synergistic effects of HDAC inhibition with immune cell therapy have not been fully explored. Natural killer (NK)
Adeleye O. Adeshakin (11358672)   +8 more
core   +1 more source

A Living Multi‐Omics PDX Biobank of High‐Risk Sarcomas Reveals ecDNA‐Driven Oncogene Amplification in Osteosarcoma and Enables Preclinical Precision Oncology

open access: yesAdvanced Science, EarlyView.
A living multi‐omics sarcoma PDX biobank is enriched for high‐risk disease and preserves key patient tumor features at histopathological and molecular levels. Integrated profiling reveals ecDNA‐driven oncogene amplification in osteosarcoma and preferential retention of ecDNA during PDX evolution.
Weisong Zhao   +34 more
wiley   +1 more source

Disabling COMPASS Promoter Licensing Shifts HDAC‐Inhibited Gastric Cancer Toward Sustained Transcriptional Suppression During Recovery

open access: yesAdvanced Science, EarlyView.
Combined inhibition of the WDR5 WIN pocket and HDAC activity converts SAHA‐induced hyperacetylation into a promoter state with reduced WDR5–COMPASS association and H3K4me3. MYC/E2F‐linked nascent transcription and biosynthetic recovery are suppressed, while apoptosis and senescence‐like features increase, resulting in sustained growth inhibition in ...
Jintian Song   +8 more
wiley   +1 more source

Structure of R306465, an HDAC inhibitor developed by Johnson & Johnson that shares structural motifs with 9a-9d series.

open access: yes, 2016
Structure of R306465, an HDAC inhibitor developed by Johnson & Johnson that shares structural motifs with 9a-9d series.
Jelena Melesina (839912)   +6 more
core   +1 more source

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors

open access: yesDisease Models & Mechanisms, 2016
Clinical management of abdominal aortic aneurysm (AAA) is currently limited to elective surgical repair because an effective pharmacotherapy is still awaited.
María Galán   +8 more
doaj   +1 more source

CDK12 Inhibition Against Group 3 Medulloblastoma With PROTAC or Molecular Glue Degrader: Resistance Mediated by Distinct Transporters and Effective Countermeasures

open access: yesAdvanced Science, EarlyView.
This study reveals novel cellular transmembrane transporters whose upregulation can confer resistance to PROTACs (ABCG2) or molecular glue degraders (SLC16A2 and ABCA2) in G3‐MB. Moreover, conventional BET inhibitors or CDK9 inhibitors can circumvent resistance to CDK12‐targeted PROTACs or CCNK‐targeted molecular glue degraders and exhibit synergistic ...
Xing Chen   +12 more
wiley   +1 more source

The Role of HDACs and HDACi in Cartilage and Osteoarthritis

open access: yesFrontiers in Cell and Developmental Biology, 2020
Epigenetics plays an important role in the pathogenesis and treatment of osteoarthritis (OA). In recent decades, HDAC family members have been associated with OA.
He Zhang   +5 more
doaj   +1 more source

HDAC inhibitors in the SCAD inhibitor kits, their target HDACs, and anti-proliferative effect against Sora cells (%).

open access: yes, 2019
HDAC inhibitors in the SCAD inhibitor kits, their target HDACs, and anti-proliferative effect against Sora cells (%).
Masahiro Shinada (6848528)   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy